Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
65
AVNS Quote, Financials, Valuation and Earnings
Last price:
$15.20
Seasonality move
:
-3.42%
Day range:
$14.87 - $15.21
52-week range:
$9.30 - $16.63
Dividend yield:
0%
P/E ratio:
45.94x
P/S ratio:
1.01x
P/B ratio:
0.91x
Volume:
501.9K
Avg. volume:
570.9K
1-year change:
-2.56%
Market cap:
$706M
Revenue:
$687.8M
EPS (TTM):
-$10.19
Analysts' Opinion
-
Consensus RatingAvanos Medical, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $14.00, Avanos Medical, Inc. has an estimated downside of -7.96% from its current price of $15.21.
-
Price Target UpsideAccording to analysts, the highest upside price target is $14.00 representing -100% upside increase from its current price of $15.21.
Fair Value
-
According to the consensus of 1 analyst, Avanos Medical, Inc. has -7.96% downside to fair value with a price target of $14.00 per share.
AVNS vs. S&P 500
-
Over the past 5 trading days, Avanos Medical, Inc. has overperformed the S&P 500 by 0.22% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Avanos Medical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Avanos Medical, Inc. has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Avanos Medical, Inc. reported revenues of $177.8M.
Earnings Growth
-
Avanos Medical, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Avanos Medical, Inc. reported earnings per share of -$0.03.
Enterprise value:
769.2M
EV / Invested capital:
--
Price / LTM sales:
1.01x
EV / EBIT:
19.14x
EV / Revenue:
1.10x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
10.27x
Price / Operating cash flow:
9.42x
Enterprise value / EBITDA:
9.58x
Gross Profit (TTM):
$362.3M
Return On Assets:
-38.89%
Net Income Margin (TTM):
-66.95%
Return On Equity:
-52.63%
Return On Invested Capital:
-44.75%
Operating Margin:
7.37%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $681.6M | $681.5M | $699.9M | $170.4M | $177.8M | |
| Gross Profit | $387.6M | $378.3M | $362.3M | $92.9M | $81.1M | |
| Operating Income | $60.2M | $62.4M | $40.2M | $16.7M | $13.1M | |
| EBITDA | $103.6M | $108.3M | $80.3M | $28.4M | $22.5M | |
| Diluted EPS | -$1.19 | $0.34 | -$10.19 | $0.09 | -$0.03 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $405M | $470M | $524.6M | $472.6M | $351.4M | |
| Total Assets | $1.6B | $1.8B | $1.7B | $1.7B | $1.1B | |
| Current Liabilities | $129.2M | $162.3M | $170.7M | $212.9M | $147.9M | |
| Total Liabilities | $336M | $511.7M | $502.8M | $426.5M | $289.7M | |
| Total Equity | $1.3B | $1.3B | $1.2B | $1.2B | $778M | |
| Total Debt | $205.8M | $290.8M | $294M | $188.5M | $124.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $53.4M | $55.5M | $104.4M | $23M | $14M | |
| Cash From Investing | -$64.3M | $61.1M | -$61.4M | -$12M | -$31.5M | |
| Cash From Financing | -$1.4M | -$136.4M | -$61.7M | -$16M | -$2M | |
| Free Cash Flow | $36.6M | $36.6M | $74.9M | $20M | $7M | |
AVNS
Sector
Market Cap
$706M
$25.8M
Price % of 52-Week High
91.46%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
3.6%
-1.67%
1-Year Price Total Return
-2.56%
-21.92%
Beta (5-Year)
1.089
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$14.88
200-day SMA
Buy
Level
$12.03
Bollinger Bands (100)
Buy
Level
10.94 - 13.14
Chaikin Money Flow
Buy
Level
16.1M
20-day SMA
Buy
Level
$13.99
Relative Strength Index (RSI14)
Buy
Level
73.67
ADX Line
Buy
Level
55.15
Williams %R
Sell
Level
-5.5888
50-day SMA
Buy
Level
$12.63
MACD (12, 26)
Buy
Level
0.76
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
12.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4372)
Buy
CA Score
(Annual)
Level (0.8856)
Buy
Beneish M-Score
(Annual)
Level (-4.5291)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.1869)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Stock Forecast FAQ
In the current month, AVNS has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AVNS average analyst price target in the past 3 months is $14.00.
-
Where Will Avanos Medical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Avanos Medical, Inc. share price will drop to $14.00 per share over the next 12 months.
-
What Do Analysts Say About Avanos Medical, Inc.?
Analysts are divided on their view about Avanos Medical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Avanos Medical, Inc. is a Sell and believe this share price will rise from its current level to $14.00.
-
What Is Avanos Medical, Inc.'s Price Target?
The price target for Avanos Medical, Inc. over the next 1-year time period is forecast to be $14.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AVNS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Avanos Medical, Inc. is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of AVNS?
You can purchase shares of Avanos Medical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Avanos Medical, Inc. shares.
-
What Is The Avanos Medical, Inc. Share Price Today?
Avanos Medical, Inc. was last trading at $15.20 per share. This represents the most recent stock quote for Avanos Medical, Inc.. Yesterday, Avanos Medical, Inc. closed at $15.21 per share.
-
How To Buy Avanos Medical, Inc. Stock Online?
In order to purchase Avanos Medical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get AVNS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AVNS
Sector
P/E ratio
45.94x
23.35x
PEG ratio
0.00x
-0.01x
P/B ratio
0.91x
1.78x
Price / LTM sales
1.01x
1.55x
Growth Metrics
AVNS
Sector
Revenue growth
4.34%
3.74%
Earnings growth
-132.72%
11.14%
Revenue (5-year growth)
-0.28%
6.38%
Earnings forecast
$0.25
-$0.19
Profitability
AVNS
Sector
Profitability FY 2024
$381.3M
$2.6M
Return on invested capital
-44.75%
-32.91%
Return on assets
-38.89%
-29.56%
Return on equity
-52.63%
-38.66%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Feb
4
Balance Sheet
AVNS
Sector
Total cash
$70.5M
$25.2M
Short term investments
--
$24.1M
Total assets
$1.2B
$72.8M
Long term debt
$124.2M
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
23
CAR alert for Feb 20
Avis Budget Group, Inc. [CAR] is down 21.87% over the past day.
Buy
75
HYMC alert for Feb 20
Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.
Sell
1
EPAM alert for Feb 20
EPAM Systems, Inc. [EPAM] is down 16.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
